EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Personalized 3D-printed TDM/ZrO2 scaffolds laden with iPSC-derived SOX9+ sclerotomal progenitors for functional osteochondral regeneration

Yuqing Dong, Zhijun Zhang, Fengxiao Zhao, Weihua Guo, Jingfei Xiong, Zhonghan Li, Yuming Zhao

International Journal of Bioprinting · 2025-10-23 · 11 (6) · 531

DOI: 10.36922/ijb025330333 ↗
AbstractBibliografische Angaben

Abstract

Osteochondral defects resulting from trauma or degenerative diseases are challenging to treat due to the complex hierarchical structure and limited self-healing capacity of articular cartilage. Recent advancements have identified SOX9-positive (SOX9+) sclerotomal progenitors (scl-progenitors), derived from human pluripotent stem cells, as a promising cell source capable of mimicking endochondral ossification and promoting osteochondral regeneration. A personalized three-dimensional (3D)-bioprinted scaffold was developed using treated dentin matrix (TDM)—a decellularized matrix rich in low-crystallinity hydroxyapatite, type I collagen, and osteoinductive factors—as the core bioactive material. To enhance mechanical strength and printability, the TDM was combined with methacrylated gelatin and zirconia nanoparticles. SOX9+ scl-progenitors were encapsulated within the hydrogel matrix and printed using extrusion-based 3D bioprinting to fabricate cell-laden scaffolds with tunable biomechanical and biological properties. The engineered constructs supported robust cell viability, proliferation, and differentiation toward osteochondral lineages in vitro. In vivo implantation in a nude rat knee osteochondral defect model demonstrated excellent biocompatibility and significant regeneration of both cartilage and subchondral bone tissue. This study presents a translatable and customizable platform integrating stem cell technology, natural biomaterials, and 3D bioprinting for osteochondral tissue engineering. The bioengineered construct offers substantial advantages for personalized osteochondral defect repair over conventional approaches.  

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →